My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 202

    1.

    ALT-946 and aminoguanidine, inhibitors of advanced glycation, improve severe nephropathy in the diabetic transgenic (mREN-2)27 rat.

    Wilkinson-Berka JL, Kelly DJ, Koerner SM, Jaworski K, Davis B, Thallas V, Cooper ME.

    Diabetes. 2002 Nov;51(11):3283-9.PMID: 12401720 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Renoprotective effects of a novel inhibitor of advanced glycation.

    Forbes JM, Soulis T, Thallas V, Panagiotopoulos S, Long DM, Vasan S, Wagle D, Jerums G, Cooper ME.

    Diabetologia. 2001 Jan;44(1):108-14.PMID: 11206401 [PubMed - indexed for MEDLINE]Related articles

    3.

    Renoprotective and anti-hypertensive effects of combined valsartan and perindopril in progressive diabetic nephropathy in the transgenic (mRen-2)27 rat.

    Wilkinson-Berka JL, Gibbs NJ, Cooper ME, Skinner SL, Kelly DJ.

    Nephrol Dial Transplant. 2001 Jul;16(7):1343-9.PMID: 11427623 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    The breakdown of preexisting advanced glycation end products is associated with reduced renal fibrosis in experimental diabetes.

    Forbes JM, Thallas V, Thomas MC, Founds HW, Burns WC, Jerums G, Cooper ME.

    FASEB J. 2003 Sep;17(12):1762-4. Epub 2003 Jul 18.PMID: 12958202 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Relative contributions of advanced glycation and nitric oxide synthase inhibition to aminoguanidine-mediated renoprotection in diabetic rats.

    Soulis T, Cooper ME, Sastra S, Thallas V, Panagiotopoulos S, Bjerrum OJ, Jerums G.

    Diabetologia. 1997 Oct;40(10):1141-51.PMID: 9349594 [PubMed - indexed for MEDLINE]Related articles

    6.

    Advanced glycation end products-cytokine-nitric oxide sequence pathway in the development of diabetic nephropathy: aminoguanidine ameliorates the overexpression of tumour necrosis factor-alpha and inducible nitric oxide synthase in diabetic rat glomeruli.

    Sugimoto H, Shikata K, Wada J, Horiuchi S, Makino H.

    Diabetologia. 1999 Jul;42(7):878-86.PMID: 10440132 [PubMed - indexed for MEDLINE]Related articles

    7.

    Attenuation of extracellular matrix accumulation in diabetic nephropathy by the advanced glycation end product cross-link breaker ALT-711 via a protein kinase C-alpha-dependent pathway.

    Thallas-Bonke V, Lindschau C, Rizkalla B, Bach LA, Boner G, Meier M, Haller H, Cooper ME, Forbes JM.

    Diabetes. 2004 Nov;53(11):2921-30.PMID: 15504973 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    The breakdown of preformed advanced glycation end products reverses erectile dysfunction in streptozotocin-induced diabetic rats: preventive versus curative treatment.

    Usta MF, Kendirci M, Gur S, Foxwell NA, Bivalacqua TJ, Cellek S, Hellstrom WJ.

    J Sex Med. 2006 Mar;3(2):242-50; discussion 250-2.PMID: 16490017 [PubMed - indexed for MEDLINE]Related articles

    9.

    Gene expression of receptor for advanced glycosylation end products and its modulation by aminoguanidine in diabetic kidney tissue.

    Huang Y, Lin S, Zhou J.

    Chin Med J (Engl). 1998 Aug;111(8):698-704.PMID: 11245022 [PubMed - indexed for MEDLINE]Related articles

    10.

    Effects of endothelin or angiotensin II receptor blockade on diabetes in the transgenic (mRen-2)27 rat.

    Kelly DJ, Skinner SL, Gilbert RE, Cox AJ, Cooper ME, Wilkinson-Berka JL.

    Kidney Int. 2000 May;57(5):1882-94.PMID: 10792607 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Effects of low-dose and early versus late perindopril treatment on the progression of severe diabetic nephropathy in (mREN-2)27 rats.

    Mifsud SA, Skinner SL, Cooper ME, Kelly DJ, Wilkinson-Berka JL.

    J Am Soc Nephrol. 2002 Mar;13(3):684-92.PMID: 11856772 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Inhibitors of advanced glycation end-products prevent loss of enteric neuronal nitric oxide synthase in diabetic rats.

    Jeyabal PV, Kumar R, Gangula PR, Micci MA, Pasricha PJ.

    Neurogastroenterol Motil. 2008 Mar;20(3):253-61. Epub 2007 Oct 17.PMID: 17971026 [PubMed - indexed for MEDLINE]Related articles

    13.

    The protective effect of aminoguanidine on erectile function in diabetic rats is not related to the timing of treatment.

    Usta MF, Bivalacqua TJ, Koksal IT, Toptas B, Surmen S, Hellstrom WJ.

    BJU Int. 2004 Aug;94(3):429-32. Erratum in: BJU Int. 2004 Oct;94(6):956. PMID: 15291881 [PubMed - indexed for MEDLINE]Related articles

    14.

    Reduction of the accumulation of advanced glycation end products by ACE inhibition in experimental diabetic nephropathy.

    Forbes JM, Cooper ME, Thallas V, Burns WC, Thomas MC, Brammar GC, Lee F, Grant SL, Burrell LA, Jerums G, Osicka TM.

    Diabetes. 2002 Nov;51(11):3274-82. Erratum in: Diabetes 2002 Dec;51(12):3592. PMID: 12401719 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    A new model of diabetic nephropathy with progressive renal impairment in the transgenic (mRen-2)27 rat (TGR).

    Kelly DJ, Wilkinson-Berka JL, Allen TJ, Cooper ME, Skinner SL.

    Kidney Int. 1998 Aug;54(2):343-52.PMID: 9690200 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Aminoguanidine inhibits albuminuria, but not the formation of advanced glycation end-products in skin collagen of diabetic rats.

    Degenhardt TP, Fu MX, Voss E, Reiff K, Neidlein R, Strein K, Thorpe SR, Baynes JW, Reiter R.

    Diabetes Res Clin Pract. 1999 Feb;43(2):81-9.PMID: 10221660 [PubMed - indexed for MEDLINE]Related articles

    17.

    The protective effect of aminoguanidine on erectile function in streptozotocin diabetic rats.

    Usta MF, Bivalacqua TJ, Yang DY, Ramanitharan A, Sell DR, Viswanathan A, Monnier VM, Hellstrom WJ.

    J Urol. 2003 Oct;170(4 Pt 1):1437-42.PMID: 14501785 [PubMed - indexed for MEDLINE]Related articles

    18.

    Effect of diabetes and aminoguanidine therapy on renal advanced glycation end-product binding.

    Youssef S, Nguyen DT, Soulis T, Panagiotopoulos S, Jerums G, Cooper ME.

    Kidney Int. 1999 Mar;55(3):907-16.PMID: 10027927 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Protein kinase C beta inhibition attenuates the progression of experimental diabetic nephropathy in the presence of continued hypertension.

    Kelly DJ, Zhang Y, Hepper C, Gow RM, Jaworski K, Kemp BE, Wilkinson-Berka JL, Gilbert RE.

    Diabetes. 2003 Feb;52(2):512-8.PMID: 12540629 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Effects of aminoguanidine in preventing experimental diabetic nephropathy are related to the duration of treatment.

    Soulis T, Cooper ME, Vranes D, Bucala R, Jerums G.

    Kidney Int. 1996 Aug;50(2):627-34.PMID: 8840295 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity